Laccure is a female health company

Focusing on an innovative consumer health product for one-time treatment of bacterial vaginosis

Today High unmet medical need

It is estimated that more than 300 million women throughout the world suffer from bacterial vaginosis every year.

Treatment with systemic or local antibiotics is the most used therapy for bacterial vaginosis. Antibiotic drugs do; however, not definitely cure the condition which often recurs soon after completed treatment. With the aim of reducing the environmental exposure to antibiotics and thereby to reduce the risk for bacterial resistance development, there is today a general ambition to reduce the use of antibiotics at conditions when they are not medically required due to a lack of efficacious treatment alternatives.

Learn more

Bacterial vaginosis

Bacterial vaginosis

Bacterial vaginosis is rated as the most common cause for women to visit their gynaecologist and the condition accounts for about half of all vaginal infections.

Laccure® Pessary

Laccure® Pessary

There are currently no effective and safe products available that are also user-friendly. Laccure has developed a unique antibiotic-free and pH-modifying vaginal pessary. Please note that Laccure® pessary is not yet CE-marked or available on the market.

Bacterial vaginosis

An imbalance in the vaginal bacterial flora

A common medical condition

The vagina naturally has an environment containing “good” and “bad” bacteria. In cases of bacterial vaginosis, there is an excess of bad bacteria. This throws the vaginal environment out of balance. The symptoms of bacterial vaginosis impact the quality of life for affected women.

Learn more

Latest press and news from Laccure

Laccure AB